SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-21-000008
Filing Date
2021-01-04
Accepted
2021-01-04 11:29:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 d8691583_13g-a.htm SC 13G/A 201285
  Complete submission text file 0000919574-21-000008.txt   202781
Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87931 | Film No.: 21500652
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address 300 PARK AVENUE, 25TH FLOOR NEW YORK NY 10022 212-808-2460
Broadfin Capital, LLC (Filed by) CIK: 0001511901 (see all company filings)

IRS No.: 202924429 | Fiscal Year End: 1231
Type: SC 13G/A